期刊文献+

缬沙坦大鼠在体肠吸收动力学 被引量:6

In situ intestinal absorption kinetics of valsartan in rats
下载PDF
导出
摘要 通过大鼠在体单向肠灌流模型(SPIP),采用反相高效液相色谱法测定大鼠肠液中缬沙坦的浓度,研究缬沙坦的肠吸收动力学与P-糖蛋白(P-gp)和有机阴离子转运多肽(OATP)对缬沙坦肠吸收的影响。结果表明,缬沙坦为全肠段吸收,吸收速率与灌流液的pH和肠段部位有关,吸收速率按十二指肠、空肠、结肠和回肠顺序下降。缬沙坦在十二指肠的非线性吸收动力学参数为Ka=0.328 h-1;Vm=72.652μmol/(L.h);Km=10.968μmol/L;Vms=69.115μmol/(L.h);Kms=0μmol/L。空肠、结肠和回肠的吸收速率常数分别为(0.595±0.091),(0.586±0.153)和(0.551±0.030)h-1。与原药组相比,含P-gp抑制剂药物组Papp显著增加,含OATP抑制剂药物组Papp显著减少(P<0.05)。缬沙坦的肠吸收机制为主动转运-被动扩散混合吸收,符合非线性动力学过程。 The aim of this study was to investigate the absorption mechanism of valsartan in various intestinal segments.Single-pass intestinal perfusion(SPIP) model was used to study the intestinal absorption kinetics of valsartan and the effects of drug transporters,including P-glycoprotein(P-gp) and organic anion transporting polypeptide(OATP),on in situ intestinal absorption at different segments in rats.Valsartan was assayed by RP-HPLC.Valsartan was absorbed in the whole intestine,and its absorption rate of valsartan was influenced by the pH of the perfusion solution and intestinal segments.The absorption rate was descended as the order of duodenum,jejunum,colon and ileum.Valsartan absorption can be described best by nonlinear dynamic absorption parameters(Ka=0.328 h-1;Vm=72.652 μmol/(L ·h);Km=10.968 μmol/L;Vms=69.115 μmol/(L ·h);Kms=0 μmol/L).The absorption rate constants(Ka) in jejunum,colon and ileum were estimated to be(0.595±0.091),(0.586±0.153) and(0.551±0.030) h-1,respectively.Group containing P-gp inhibitor had marked increased of Papp,while for OATP inhibitor,Papp was significantly decreased(P0.05).In conclusion,the intestinal absorption mechanism of valsartan was demonstrated to be the combination of active transport and passive diffusion,according with the nonlinear kinetics.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2012年第2期130-136,共7页 Journal of China Pharmaceutical University
基金 国家"重大新药创制"科技重大专项资助项目(No.2009ZX09310-004)~~
关键词 缬沙坦 单向肠灌流 P-糖蛋白 有机阴离子转运多肽 valsartan single-pass intestinal perfusion P-glycoprotein organic anion transporting polypeptide This study was supported by China National Key High-Tech Innovation Project for the R&D of Novel Drugs(No.2009ZX09310-004)
  • 相关文献

参考文献1

二级参考文献14

  • 1贺云霞,孙进,程刚.多药耐药性P-糖蛋白在药物肠道吸收中的作用[J].沈阳药科大学学报,2004,21(5):389-393. 被引量:23
  • 2聂淑芳,潘卫三,杨星钢,刘宏飞,刘志东.对大鼠在体肠单向灌流技术中重量法的评价[J].中国新药杂志,2005,14(10):1176-1179. 被引量:90
  • 3胡一桥,郑梁元,钱陈钦,郁伟海.离子型药物酚红的小肠吸收研究[J].中国药科大学学报,1996,27(6):355-359. 被引量:56
  • 4Janice H,Barry HH.Intestinal secretion of drugs.The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption[J].Adv Drug Deliv Rev,1997,25(2):129-157.
  • 5Yan L,Ming H.Absorption and metabolism of flavonoids in the Caco-2 cell culture model and a perfused rat intestinal model[J].J Pharmacol Exp Ther,2002,30(4):370-377.
  • 6Cook TJ,Shenoy SS.Intestinal permeability of chlorpyrifos using the single-pass intestinal perfusion method in the rat[J].Toxicol,2003,184(2):125-133.
  • 7Carolyn LC,Laurent S,Michael JR,et al.In vivo modulation of intestinal CYP3A metabolism by P-glycoprotein:studies using the rat single-pass intestinal perfusion model[J].J Pharmacol Exp Ther,2003,305(1):306-314.
  • 8Fagerholm M,Johansson M,Lennernas H.Comparsion between per-meability coefficients in rat and human jejunum[J].Pharm Res,1996,13(9):1 336-1 342.
  • 9Bowey E,Adlercreutz H,Rowland I.Metabolism of isoflavones and lignans by the gut microflora:a study in germ-free and human flora associated rats[J].Food Chem Toxicol,2003,41(5):631-636.
  • 10孔肇路.多药耐药相关蛋白的生物学特性与作用机制的研究进展[J].中国癌症杂志,2001,11(4):375-378. 被引量:11

共引文献20

同被引文献39

引证文献6

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部